Resistance of MBL gene-knockout mice to experimental systemic aspergillosis

Immunology Letters

Volumn 128, Issue 2, 2010, Pages 105-107

  Clemons, Karl V ^a,b,c   Martinez, Marife ^a   Tong, Ann Jay ^a   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Aspergillosis; Aspergillus fumigatus; Mannose binding lectin; MBL

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 1; MANNOSE BINDING LECTIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; C57BL 6 MOUSE; CONIDIUM; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; INFECTION RESISTANCE; INFECTION SENSITIVITY; INOCULATION; KNOCKOUT GENE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; WILD TYPE;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MANNOSE-BINDING LECTIN; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; SURVIVAL ANALYSIS;

EID: 77249117655     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.12.021     Document Type: Article

References (33)

1. Crouch E., Hartshorn K., Ofek I. Collectins and pulmonary innate immunity. Immunol Rev 2000, 173:52-65.
2. Crouch E.C. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998, 19:177-201.
3. Madan T., Kaur S., Saxena S., Singh M., Kishore U., Thiel S., et al. Role of collectins in innate immunity against aspergillosis. Med Mycol 2005, 43(Suppl. 1):S155-S163.
4. Worthley D.L., Bardy P.G., Mullighan C.G. Mannose-binding lectin: biology and clinical implications. Intern Med J 2005, 35:548-555.
5. Brummer E, Stevens DA. Collectins and fungal pathogens: role of surfactant proteins and mannose binding lectin in host resistance. Med Mycol; Epub date 2009/07/30, pages 1-13, PMID: 19639514. doi:10.1080/13693780903117473.
6. Eisen D.P., Minchinton R.M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003, 37:1496-1505.
7. Jack D.L., Turner M.W. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003, 31:753-757.
8. Jensenius J.C., Jensen P.H., McGuire K., Larsen J.L., Thiel S. Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans 2003, 31:763-767.
9. Turner M.W. The role of mannose-binding lectin in health and disease. Mol Immunol 2003, 40:423-429.
10. Babula O., Lazdane G., Kroica J., Ledger W.J., Witkin S.S. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003, 37:733-737.
11. Liu F., Liao Q., Liu Z. Mannose-binding lectin and vulvovaginal candidiasis. Int J Gynaecol Obstet 2006, 92:43-47.
12. Pellis V., De Seta F., Crovella S., Bossi F., Bulla R., Guaschino S., et al. Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin Exp Immunol 2005, 139:120-126.
13. Petersen K.H., Matthiesen F., Agger T., Kongerslev L., Thiel S., Cornelissen K., et al. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 2006, 26:564-575.
14. Kaur S., Gupta V.K., Thiel S., Sarma P.U., Madan T. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol 2007, 148:382-389.
15. Hanson L.H., Clemons K.V., Denning D.W., Stevens D.A. Efficacy of oral saperconazole in systemic murine aspergillosis. J Med Vet Mycol 1995, 33:311-317.
16. Clemons K.V., Grunig G., Sobel R.A., Mirels L.F., Rennick D.M., Stevens D.A. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000, 122:186-191.
17. Clemons K.V., Miller T.K., Selitrennikoff C.P., Stevens D.A. fos-1, a putative histidine kinase as a virulence factor for systemic aspergillosis. Med Mycol 2002, 40:259-262.
18. Capilla Luque J., Clemons K.V., Stevens D.A. Efficacy of micafungin alone or in combination against systemic murine aspergillosis. Antimicrob Agents Chemother 2003, 47:1452-1455.
19. Hogaboam C.M., Takahashi K., Ezekowitz R.A., Kunkel S.L., Schuh J.M. Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J Leukoc Biol 2004, 75:805-814.
20. Takahashi K., Gordon J., Liu H., Sastry K.N., Epstein J.E., Motwani M., et al. Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect 2002, 4:773-784.
21. Lee S.J., Gonzalez-Aseguinolaza G., Nussenzweig M.C. Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice. Mol Cell Biol 2002, 22:8199-8203.
22. Clemons K.V., Stevens D.A. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med Mycol 2005, 43(Suppl. 1):S101-S110.
23. Crosdale D.J., Poulton K.V., Ollier W.E., Thomson W., Denning D.W. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001, 184:653-656.
24. Vaid M., Kaur S., Sambatakou H., Madan T., Denning D.W., Sarma P.U. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007, 45:183-186.
25. Kaur S., Gupta V.K., Shah A., Thiel S., Sarma P.U., Madan T. Elevated levels of mannan-binding lectin (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006, 143:414-419.
26. Lambourne J., Agranoff D., Herbrecht R., Troke P.F., Buchbinder A., Willis F., et al. Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2009, 49:1486-1491.
27. Balloy V., Huerre M., Latge J.P., Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005, 73:494-503.
28. Duong M., Ouellet N., Simard M., Bergeron Y., Olivier M., Bergeron M.G. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis 1998, 178:1472-1482.
29. Stephens-Romero S.D., Mednick A.J., Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005, 73:114-125.
30. Brummer E., Capilla J., Bythadka L., Stevens D.A. Production of IL-6, in contrast to other cytokines and chemokines, in macrophage innate immune responses: effect of serum and fungal (Blastomyces) challenge. Cytokine 2007, 39:163-170.
31. Ezekowitz R.A. Role of the mannose-binding lectin in innate immunity. J Infect Dis 2003, 187(Suppl. 2):S335-S339.
32. Koneti A., Linke M.J., Brummer E., Stevens D.A. Evasion of innate immune responses: evidence for mannose binding lectin inhibition of tumor necrosis factor alpha production by macrophages in response to Blastomyces dermatitidis. Infect Immun 2008, 76:994-1002.
33. Stevens D.A. A possible mechanism for synergy between antifungal therapy and immune defenses. J Infect Dis 2008, 198:159-162.